Mukka Proteins Limited (NSE:MUKKA)
India · Delayed Price · Currency is INR 24.98
-0.49 (-1.92%)
Feb 13, 2026, 3:30 PM IST
Mukka Proteins Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 14,343 | 10,064 | 13,798 | 11,771 | 7,705 | 6,038 |
Other Revenue | 178.69 | - | - | 13.99 | 14.36 | 7.65 |
| 14,521 | 10,064 | 13,798 | 11,785 | 7,719 | 6,046 | |
Revenue Growth (YoY) | 64.35% | -27.06% | 17.08% | 52.67% | 27.68% | 9.51% |
Cost of Revenue | 11,822 | 7,760 | 11,367 | 9,429 | 6,358 | 5,144 |
Gross Profit | 2,699 | 2,304 | 2,431 | 2,356 | 1,362 | 901.62 |
Selling, General & Admin | 371.35 | 332.22 | 297.61 | 249.05 | 205.38 | 165.59 |
Other Operating Expenses | 1,193 | 1,005 | 1,051 | 1,227 | 655.19 | 503.37 |
Operating Expenses | 1,708 | 1,472 | 1,472 | 1,595 | 946.64 | 752.39 |
Operating Income | 991.64 | 831.9 | 959.17 | 761.01 | 414.97 | 149.23 |
Interest Expense | -372.83 | -266.17 | -189.92 | -116.21 | -75.59 | -73.27 |
Interest & Investment Income | 37.29 | 37.29 | 31.66 | 16.81 | 13.09 | 9.06 |
Earnings From Equity Investments | 18.52 | 10.68 | 31.06 | 14.6 | 10.12 | 38.21 |
Currency Exchange Gain (Loss) | 80.94 | 80.94 | 92.87 | - | 11.24 | 29.23 |
Other Non Operating Income (Expenses) | -92.69 | -92.69 | -54.24 | -27.96 | -15.4 | -1.25 |
EBT Excluding Unusual Items | 662.87 | 601.95 | 870.6 | 648.25 | 358.43 | 151.21 |
Gain (Loss) on Sale of Investments | 0.16 | 0.16 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0.55 | 0.55 | 3.95 | -2.66 | 0.93 | 3.34 |
Other Unusual Items | - | - | - | 1.33 | - | - |
Pretax Income | 663.58 | 602.66 | 874.55 | 659.43 | 359.8 | 154.55 |
Income Tax Expense | 166.31 | 121.69 | 131.5 | 184.18 | 101.61 | 44.45 |
Earnings From Continuing Operations | 497.27 | 480.97 | 743.05 | 475.25 | 258.19 | 110.1 |
Minority Interest in Earnings | -46.16 | -16.38 | -42.53 | -34.5 | -16.11 | -20.34 |
Net Income | 451.11 | 464.59 | 700.52 | 440.75 | 242.08 | 89.76 |
Net Income to Common | 451.11 | 464.59 | 700.52 | 440.75 | 242.08 | 89.76 |
Net Income Growth | -24.87% | -33.68% | 58.94% | 82.07% | 169.70% | -31.88% |
Shares Outstanding (Basic) | 301 | 300 | 226 | 220 | 220 | 220 |
Shares Outstanding (Diluted) | 301 | 300 | 226 | 220 | 220 | 220 |
Shares Change (YoY) | 5.67% | 32.93% | 2.58% | - | - | - |
EPS (Basic) | 1.50 | 1.55 | 3.10 | 2.00 | 1.10 | 0.41 |
EPS (Diluted) | 1.50 | 1.55 | 3.10 | 2.00 | 1.10 | 0.41 |
EPS Growth | -28.90% | -50.11% | 54.94% | 82.13% | 169.61% | -31.88% |
Free Cash Flow | - | -1,360 | -1,680 | -655.62 | -17.03 | -47.28 |
Free Cash Flow Per Share | - | -4.54 | -7.45 | -2.98 | -0.08 | -0.21 |
Gross Margin | 18.59% | 22.89% | 17.62% | 19.99% | 17.64% | 14.91% |
Operating Margin | 6.83% | 8.27% | 6.95% | 6.46% | 5.38% | 2.47% |
Profit Margin | 3.11% | 4.62% | 5.08% | 3.74% | 3.14% | 1.49% |
Free Cash Flow Margin | - | -13.52% | -12.18% | -5.56% | -0.22% | -0.78% |
EBITDA | 1,104 | 948.83 | 1,082 | 879.74 | 496.42 | 232.53 |
EBITDA Margin | 7.60% | 9.43% | 7.84% | 7.46% | 6.43% | 3.85% |
D&A For EBITDA | 112.24 | 116.93 | 123.19 | 118.73 | 81.45 | 83.3 |
EBIT | 991.64 | 831.9 | 959.17 | 761.01 | 414.97 | 149.23 |
EBIT Margin | 6.83% | 8.27% | 6.95% | 6.46% | 5.38% | 2.47% |
Effective Tax Rate | 25.06% | 20.19% | 15.04% | 27.93% | 28.24% | 28.76% |
Revenue as Reported | 14,672 | 10,215 | 13,961 | 11,838 | 7,761 | 6,100 |
Advertising Expenses | - | - | - | - | 6.22 | 5.72 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.